United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

j m mcgill ltd - potassium bicarbonate; sodium alginate - chewable tablet - 100mg ; 500mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

colorama pharmaceuticals ltd - potassium bicarbonate; sodium alginate - chewable tablet - 100mg ; 500mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

am distributions (yorkshire - potassium bicarbonate; sodium alginate - chewable tablet - 100mg ; 500mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

niche pharma ltd - potassium bicarbonate; sodium alginate - chewable tablet - 100mg ; 500mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - potassium bicarbonate; sodium alginate - chewable tablet - 100mg ; 500mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

ennogen healthcare ltd - potassium bicarbonate; sodium alginate - chewable tablet - 100mg ; 500mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

forum health products ltd - potassium bicarbonate; sodium alginate - chewable tablet - 100mg ; 500mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

reckitt benckiser healthcare (uk) ltd - potassium bicarbonate; sodium alginate - chewable tablet - 100mg ; 500mg

United States - English - NLM (National Library of Medicine)

upsher-smith laboratories, inc. - potassium bicarbonate (unii: hm5z15lebn) (potassium cation - unii:295o53k152) - potassium cation 978 mg - - for the treatment of patients with hypokalemia, with or without metabolic alkalosis; in digitalis intoxication; and in patients with hypokalemic familial periodic paralysis. if hypokalemia is the result of diuretic therapy, consideration should be given to the use of a lower dose of diuretic, which may be sufficient without leading to hypokalemia. - for the prevention of hypokalemia in patients who would be at particular risk if hypokalemia were to develop (e.g., digitalized patients or patients with significant cardiac arrhythmias). the use of potassium salts in patients receiving diuretics for uncomplicated essential hypertension is often unnecessary when such patients have a normal dietary pattern and when low doses of the diuretic are used. serum potassium should be checked periodically, however, and if hypokalemia occurs, dietary supplementation with potassium-containing foods may be adequate to control milder cases. in more severe cases, and if dose adjustment of the diuretic is ineffective or unwarra

Ireland - English - HPRA (Health Products Regulatory Authority)

reckitt benckiser ireland ltd - potassium bicarbonate; sodium alginate - chewable tablet - 500/100 milligram(s) - other drugs for peptic ulcer and gastro-oesophageal reflux disease (gord); alginic acid